RedHill Biopharma (RDHL) Stock Price

$4.76 2.9%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    2

  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on RedHill Biopharma, AI stock picks, stock alerts and much more.

Sign up

RDHL AI Stock Analysis

AI stock analysis for RDHL is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like RedHill Biopharma (RDHL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

RedHill Biopharma (RDHL) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of RedHill Biopharma (RDHL), currently trading at $4.76, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About RDHL

LSE

  • RedHill Biopharma Ltd.

  • Symbol

    RDHL

  • Market

    NASDAQ

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    6.1M

Similar Stocks

TXMD TherapeuticsMD
TXMD		 $1.3
28.7%
4
TLRY Tilray
TLRY		 $0.9515
9.7%
3
CGC Canopy Growth
CGC		 $1.63
1.2%
2
ACB Aurora Cannabis
ACB		 $5.89
0.5%
4
SNDL Sundial Growers
SNDL		 $1.77
0.6%
3

News

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court
December 2, 2024. prnewswire.com

RDHL Alternative Data

Web Traffic

RedHill Biopharma receives an estimated 4008 monthly visitors to redhillbio.com.

  • Web Traffic

    4008

  • Change from Previous Month

    34.9%

  • 3 Month Change

    9.6%

  • YoY Change

    9.6%

Reddit Mentions

RedHill Biopharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

News Mentions

RedHill Biopharma was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

RedHill Biopharma has 1,352 Twitter Followers on its main Twitter (also known as X) account, which is down by -1.1% over the last month.

  • Twitter Followers

    1352

  • Daily Change

    0.1%

  • 1 Month Change

    1.1%

  • 3 Month Change

    12.8%

  • YoY Change

    12.8%

LinkedIn Followers

6,744 are following RedHill Biopharma on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    6744

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    2.2%

Job Postings

RedHill Biopharma currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, RedHill Biopharma has 53 employees.

  • LinkedIn Employees

    53

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    5.4%

  • YoY Change

    5.4%

Business Outlook

  • Business Outlook

    38

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

RDHL Financials

RDHL Key Metrics

  • Total Revenue

    $1.8M

  • Net Income

    $761K

  • Earnings per Share

    $0.19

  • Free cash flow

    -$10.6M

  • EBITDA

    $2.7M

  • EBITDA Ratio

    1.4961

  • Total Assets

    $35M

RDHL 2-year Revenue & Income
RDHL 2-year Free Cash Flow

RDHL Technicals

RDHL SMA
RDHL RSI

FAQ

What's the current price of RedHill Biopharma (RDHL) Stock?
The price of an RedHill Biopharma (RDHL) share is $4.76.

What's the market cap of RedHill Biopharma?
The current market cap of RedHill Biopharma is 6.1M.

Should I buy or sell RDHL?
RedHill Biopharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, RedHill Biopharma is better viewed as a hold or accumulate position while waiting for further developments.

Is RedHill Biopharma a good investment?
The current analysis of RedHill Biopharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in RedHill Biopharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy RedHill Biopharma (RDHL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for RedHill Biopharma stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to RedHill Biopharma (RDHL) that investors often compare it to?
RedHill Biopharma (RDHL) is often compared to similar stocks such as TherapeuticsMD, Tilray, Canopy Growth, Aurora Cannabis and Sundial Growers.

What is the forecast for RedHill Biopharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast RedHill Biopharma's stock price to be around $4.51 in 2026. Starting from the current price of $4.76, this represents a 5.3% change in price, indicating a bearish outlook for the stock.

How to buy RedHill Biopharma (RDHL) Stock?
RedHill Biopharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy RedHill Biopharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.